Monday, November 9, 2026

USD/CNH Falls By 1% In The Last 10 Sessions

ViaNews Editorial Team

January 18, 2024

USD/CNH Falls By 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.26% for the last 10 sessions. At 10:10 EST on Thursday, 18 January, USD/CNH (USDCNH) is $7.22.

USD/CNH's yearly highs and lows, it's 0.165% up from its 52-week low and 0.042% down from its 52-week high.

News about

  • Eur/usd price analysis: edges lower to near 1.0910, MACD suggests trend change to bearish. According to FXStreet on Tuesday, 16 January, "A breakthrough above the latter could inspire the EUR/USD pair's bulls to explore the region around the psychological level at 1.1000 followed by January's high at 1.1038.", "A break below the support zone could put pressure on the EUR/USD pair to navigate the further region around the 38.2% Fibonacci retracement at 1.0867 level followed by the major support at 1.0850 level."
  • According to FXStreet on Tuesday, 16 January, "The EUR/USD fell to its lowest bids since mid-December, knocking below the 1.0900 handle and testing into 1.0870 as bearish pressure builds enough to knock the pair out of near-term consolidation.", "The EUR/USD is approaching the 200-day Simple Moving Average (SMA) near 1.0850, cutting cleanly through the 50-day SMA at 1.0900 as the pair heads into a technical congestion zone. "
  • Eur/usd seen at risk of dipping to 1.05 on a thee-month view – rabobank. According to FXStreet on Tuesday, 16 January, "We see risk of EUR/USD dipping to 1.05 on a thee-month view mostly on the back of the market pushing back its expectations regarding Fed rate cuts."
  • Eur/usd analysis: stability with a bearish bias - 16 January 2024. According to DailyForex on Tuesday, 16 January, "Regarding the near-term EUR/USD outlook, the analyst says: "Broader technical signals continue to point to a major peak/reversal forming around the Euro top above the 1.11 resistance at the turn of the year. ", "For his part, Tanmay Purohit, a technical analyst at Société Générale, said, "The EUR/USD price's move upward from its lowest levels in October 2023 faced temporary resistance near the 1.1100-1.1150 graphic levels, which represents its highest levels in April 2023"."
  • Eur/usd price analysis: hovers above the 38.2% fibonacci, edges lower to near 1.0870. According to FXStreet on Wednesday, 17 January, "If the EUR/USD pair manages to break above the 1.0950 level, it could inspire bullish momentum, allowing traders to explore the region around the psychological level at 1.1000. ", "The 14-day Relative Strength Index (RSI), a momentum oscillator that measures the speed and change of price movements, for the EUR/USD pair, is positioned below the 50 mark, indicating a bearish momentum in the market. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com